Sera Prognostics Correlations

SERA Stock  USD 3.79  0.14  3.56%   
The current 90-days correlation between Sera Prognostics and Fonar is -0.18 (i.e., Good diversification). The correlation of Sera Prognostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Sera Prognostics Correlation With Market

Modest diversification

The correlation between Sera Prognostics and DJI is 0.24 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sera Prognostics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sera Prognostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.

Moving together with Sera Stock

  0.9EYEN EyenoviaPairCorr
  0.63MOLN Molecular PartnersPairCorr
  0.88CLDX Celldex TherapeuticsPairCorr
  0.92CRNX Crinetics PharmaceuticalsPairCorr
  0.67CRVS Corvus PharmaceuticalsPairCorr
  0.86MODD Modular MedicalPairCorr
  0.77APYX Apyx MedicalPairCorr
  0.92SGHT Sight SciencesPairCorr
  0.86SRDX SurModicsPairCorr
  0.76CNMD CONMEDPairCorr

Moving against Sera Stock

  0.92FNA Paragon 28PairCorr
  0.89CPIX Cumberland PharmaceuticalsPairCorr
  0.71CMRX ChimerixPairCorr
  0.52OPT OptheaPairCorr
  0.94NVRO Nevro CorpPairCorr
  0.89LUCD Lucid DiagnosticsPairCorr
  0.73INMD InModePairCorr
  0.73NYXH NyxoahPairCorr
  0.64LUNG Pulmonx CorpPairCorr
  0.4MASI MasimoPairCorr
  0.38KIDS Orthopediatrics CorpPairCorr
  0.86FWEDF Fireweed ZincPairCorr
  0.83TOI Oncology Institute Earnings Call This WeekPairCorr
  0.82BRK-B Berkshire HathawayPairCorr
  0.81BRK-A Berkshire HathawayPairCorr
  0.64TMCI Treace Medical ConceptsPairCorr
  0.62TRGGF Tarachi Gold CorpPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SHCFONR
SHCBNR
PSNLBNR
PSNLSHC
BNRFONR
PSNLFONR
  
High negative correlations   
DRIOXGN
PSNLPMD
DRIOPMD
PMDSHC
PMDXGN
PSNLGTH

Risk-Adjusted Indicators

There is a big difference between Sera Stock performing well and Sera Prognostics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sera Prognostics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
FONR  1.34 (0.16) 0.00 (1.19) 0.00 
 2.50 
 10.83 
BNR  3.88 (0.11) 0.00 (0.25) 0.00 
 8.52 
 26.46 
OLK  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
LMDX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
GTH  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
XGN  4.91 (0.18) 0.00 (0.14) 0.00 
 15.86 
 42.16 
SHC  1.44 (0.08) 0.00 (0.15) 0.00 
 2.40 
 12.51 
PMD  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
DRIO  6.22  0.56  0.06 (2.41) 8.89 
 11.29 
 121.18 
PSNL  5.62  0.57  0.06  0.08  5.57 
 9.82 
 61.04 

Sera Prognostics Corporate Management

Benjamin JDGeneral CounselProfile
Steven GravesCoFounder BoardProfile
Sean MDCoFounder BoardProfile
John BonifaceChief OfficerProfile
Paul KearneyChief OfficerProfile